Literature DB >> 7060749

Maintenance and suppression of behavior by intravenous nicotine injections in squirrel monkeys.

S R Goldberg, R D Spealman.   

Abstract

Nicotine appears to be a contributing factor in maintaining cigarette smoking, but experimental evidence for its reinforcing effects is scarce. Indeed, it has been suggested that in some situations nicotine may have noxious properties, which limit smoking behavior. These ideas were explored by comparing the effects of intravenous injections of nicotine on behavior of squirrel monkeys under two experimental procedures. Under a fixed-interval schedule of nicotine self-administration, responding was well maintained by injections of 30-300 microgram/kg of nicotine. Nicotine-maintained responding could be reduced by presession treatment with the nicotine antagonist, mecamylamine, or by substitution of saline for nicotine. In a second experiment, responding was maintained under a two-component fixed-ratio schedule of food presentation in which responses during one component (punishment component) also resulted in injections of 10-30 microgram/kg of nicotine. Nicotine markedly suppressed responding during the punishment component but not during the alternating nonpunishment components. The suppressant effects of nicotine could be reversed by presession treatment with either mecamylamine or the antianxiety drug chlordiazepoxide, or by substitution of saline for nicotine. Nicotine had pronounced effects both as a reinforcer and as a punisher; the nature of the effects depended on the schedule under which nicotine was administered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060749

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  22 in total

1.  The influence of behavior analysis on the surgeon general's report, the health consequences of smoking: Nicotine addiction.

Authors:  J E Henningfield; S T Higgins
Journal:  Behav Anal       Date:  1989

2.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

Review 3.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

4.  Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system.

Authors:  S R Tella; B Ladenheim; A M Andrews; S R Goldberg; J L Cadet
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

Review 5.  Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability.

Authors:  Christie D Fowler; Paul J Kenny
Journal:  Neuropharmacology       Date:  2013-09-18       Impact factor: 5.250

6.  Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys.

Authors:  Zuzana Justinova; Bernard Le Foll; Godfrey H Redhi; Athina Markou; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2015-07-08       Impact factor: 4.530

7.  Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug.

Authors:  S I Dworkin; S Mirkis; J E Smith
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

8.  Preference in rhesus monkeys given a choice between cocaine and d,l-cathinone.

Authors:  W L Woolverton; C E Johanson
Journal:  J Exp Anal Behav       Date:  1984-01       Impact factor: 2.468

9.  Response suppression by visual stimuli paired with postsession d-amphetamine injections in the pigeon.

Authors:  J R Glowa; J E Barrett
Journal:  J Exp Anal Behav       Date:  1983-01       Impact factor: 2.468

10.  Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily.

Authors:  Colin S Cunningham; Megan J Moerke; Martin A Javors; F Ivy Carroll; Lance R McMahon
Journal:  Br J Pharmacol       Date:  2016-11-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.